Synthon is a Dutch pharmaceutical company which develops and manufactures generic human medicines. Expanding its business activities, Synthon is also engaged in the research and development of biotechnology-based medicines.

Synthon's head office is in Nijmegen, the Netherlands, and the company has nine affiliates abroad. The company employs around 1.250 staff of whom over 350 work in Nijmegen.

Synthon products are licensed out to third parties and are marketed worldwide.

The company culture is characterized by a determined and entrepreneurial spirit.

Synthon has recently started the development of biopharmaceutical medicines. Focusing on the development of bio therapeutic proteins, this highly innovative activity will cover a wide spectrum of technologies: from molecular biology, cell culture to protein purification, analytics and formulation. We have a professional and international team and recently announced the start of construction of our new Biopharmaceutical development laboratories.